Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
Immunogenetics|November 8, 2015
Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patientsHanen Ouadani, Imen Ben-Mustapha, Meriem Ben-ali, et al.La Tunisie Medicale|June 26, 2002
[Bronchopulmonary aspergillosis: study of 17 cases]Rym Ben Abdallah, Slaheddine Belhadj, Kalthoum Kallel, et al.Blood|September 13, 2011
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patientsMonia Ouederni, Quentin B Vincent, Pierre Frange, et al.Blood|June 2, 2011
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-upM Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.Frontiers in Immunology|March 13, 2026
Predictive factors for severity and poor treatment response in children with Evans syndrome: A retrospective cohort studyMonia Ben Khaled, Marwa Ben Ayed, Zaid Zaroui, et al.Comptes Rendus Biologies|March 30, 2013
Differentiation of Fanconi anemia and aplastic anemia using mitomycin C test in TunisiaFaten Talmoudi, Olfa Kilani, Wiem Ayed, et al.Frontiers in Immunology|January 27, 2023
Diagnostic challenge in a series of eleven patients with hyper IgE syndromesRoukaya Yaakoubi, Najla Mekki, Imen Ben-Mustapha, et al.La Tunisie Medicale|February 13, 2019
Primary Immunodeficiencies: Epidemiology in the MaghrebAhmed Aziz Bousfiha, Abderrrahmane Errami, Leila Jeddane, et al.Journal of Clinical Immunology|November 8, 2019
Genetic Approaches for Definitive Diagnosis of Agammaglobulinemia in Consanguineous FamiliesMeriem Ben-Ali, Nadia Kechout, Najla Mekki, et al.Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.Pageof 11